The purpose of this investigation was to determine whether there is a relation between impaired insulin-stimulated glucose utilization, or insulin resistance, and blood pressure (BP) in a young adult black population. Clinically well, young black men and women, including normotensive (BP< 135/85 mm Hg, n=23) and borderline hypertensive (BP> 135/85 mm Hg, n=27) individuals, were studied. Each subject had an oral glucose tolerance test (OGTT) and underwent a euglycemic hyperinsulinemic clamp procedure. A two-way analysis of variance demonstrated a significantly greater fasting insulin plasma concentration (P<.02) and sum of insulin levels during the OGTT (P=.O4) in the borderline hypertensive compared with normotensive subjects. In both BP groups, women had significantly higher fasting plasma insulin levels than men (P<.02 and /*=.009). Body mass index was a significant covariate of the plasma insulin concentration. Data obtained from the clamp demonstrated significant insulin resistance in borderline hypertensive compared with normotensive subjects (4.69±0.50 versus 6.57 ±0.63 mg/kg per minute, P=.OO2). A stepwise multiple linear regression analysis demonstrated that there are significant multiple correlations of insulin resistance with body mass index, clamped insulin level, BP group, and systolic BP (multiple/?=.7862,P<.001). Application of this analysis to the nonobese sample (n=33) found significant correlations of insulin resistance with sex, BP group, and systolic BP (multiple /J=.6817, P<.001). These data indicate that insulin resistance is present in young adult blacks with only borderline hypertension, and there is a relation between insulin sensitivity and blood pressure independent of body mass index. Also detected are significant gender differences in insulin-stimulated glucose utilization. Because of a peripheral cell defect in insulin-mediated glucose utilization, a greater quantity of insulin is necessary to achieve metabolic control of glucose. Subsequent compensatory increases in insulin secretion result in hyperinsulinemia. Hyperinsulinemia is a characteristic feature of obesity and non-insulin-dependent diabetes mellitus (NIDDM). Clinical investigations have also demonstrated a correlation of hyperinsulinemia and insulin resistance with hypertension, independent of NIDDM or obesity. 47 Although hypertension and hyperinsulinemia may be coexisting phenomena, it is also possible that insulin may contribute to the development of hypertension. This concept is supported by investigations in young populations. young adults. In another investigation of young blacks, insulin resistance as determined with the hyperinsulinemic clamp was present in nonobese, nondiabetic males with only borderline hypertension compared with matched normotensive subjects.
levated plasma insulin concentration, or hyperinsulinemia, is now established as a risk factor for cardiovascular disease. 1 -2 Insulin resistance and hyperinsulinemia are coexisting clinical phenomena. Insulin resistance, as determined in vivo, is a suboptimal metabolic response to insulin stimulation. 3 Because of a peripheral cell defect in insulin-mediated glucose utilization, a greater quantity of insulin is necessary to achieve metabolic control of glucose. Subsequent compensatory increases in insulin secretion result in hyperinsulinemia. Hyperinsulinemia is a characteristic feature of obesity and non-insulin-dependent diabetes mellitus (NIDDM) . Clinical investigations have also demonstrated a correlation of hyperinsulinemia and insulin resistance with hypertension, independent of NIDDM or obesity. 47 Although hypertension and hyperinsulinemia may be coexisting phenomena, it is also possible that insulin may contribute to the development of hypertension. This concept is supported by investigations in young populations. In the Tecumseh population, Julius et al 8 reported significantly higher fasting plasma insulin concentrations in individuals with borderline hypertension compared with normotensive Prospective investigations have demonstrated that aging, body mass or adiposity, and carbohydrate intolerance are all related to the incidence of hypertension. 10 Insulin resistance also correlates with aging, adiposity, and carbohydrate intolerance. The prevalence of hypertension is greater in black populations, 1112 and the occurrence of the risk factors related to insulin resistance (obesity and NIDDM) are also greater in black populations in the United States. It would be expected that the insulin-resistant phenotype would be linked with hypertension among blacks. However, in a multiracial study on an obese normotensive sample, Saad et al 13 detected a correlation of insulin resistance with blood pressure in whites and Native Americans but not in blacks. In black populations in the United States, no longitudinal data are yet available to examine prospectively the contribution of insulin to the development of hypertension. In a longitudinal study of Mexican Americans and non-Hispanic whites, Haffner et al 14 identified a cluster of metabolic changes, including plasma insulin, glucose, and lipid concentrations, that preceded the occurrence of hypertension. The results of their study suggest that metabolic changes, including hyperinsulinemia, may actually precede the development of hypertension. The purpose of this investigation was to deter-mine if there is a relation between elevated blood pressure and insulin resistance and hyperinsulinemia in a population of young adult blacks.
Methods

Population
Insulin-mediated glucose metabolism as a determinant of blood pressure level was examined in a young, clinically well population. We used an oral glucose tolerance test (OGTT) with measurement of plasma glucose, insulin, and C peptide after a standard glucose challenge to evaluate insulin response to glucose stimulation. A euglycemic hyperinsulinemic clamp procedure was used to quantify insulin-stimulated glucose utilization. The protocol for this study was approved by the Institutional Review Boards of the Medical College of Pennsylvania and Hahnemann University. Written informed consent was obtained from all participants at the time of enrollment. Subjects were all young adult blacks, ranging in age from 22 to 28 years. Each participant was drawn from a population that has been under study in ongoing investigations of blood pressure regulation since adolescence. Repeated measurements of growth and blood pressure are on record for each subject. This investigation excluded subjects who were treated with antihypertensive medications. Individuals with either insulin-dependent diabetes mellitus or NIDDM were also excluded.
Procedures
Enrollment assessment consisted of physical examination, anthropometric measurements (height, weight, skinfold thickness, waist-to-hip circumference ratio), and blood pressure determination. Casual systolic (first phase) and diastolic (fifth phase) blood pressure measurements were obtained by auscultation with a mercury column baumanometer with subjects in the seated position after a 10-minute rest period. The average of two determinations was used as the blood pressure at the time of the metabolic evaluation. A history of the subject's diet was taken, and he or she was asked to continue his or her usual dietary patterns through completion of the protocol. For this population, the dietary average consisted of 14% protein, 31% fat, and 55% carbohydrate. No subject had a diet that deviated significantly from this average. After the enrollment assessment, each subject returned to the clinical research unit for an OGTT scheduled in the morning after a 12-hour fast. A fasting blood sample was obtained, and then a 75-g glucose solution (Glucola, Ames Laboratories, Elkhart, Ind) was taken orally. Blood samples were obtained at 30, 60, and 120 minutes after ingestion of the glucose load. Each blood sample was immediately centrifuged. Plasma was removed and stored at -80°C until the samples were assayed for plasma glucose, insulin, and C peptide concentrations.
The euglycemic hyperinsulinemic clamp methodology measures insulin-stimulated glucose utilization (or disappearance) under steady-state conditions. 1516 With the clamp technique, insulin concentration is elevated to a predetermined level by a primed constant infusion of insulin. During physiological hyperinsulinemia, euglycemia is maintained with an infusion of exogenous glucose. During steady-state hyperinsulinemia, the glucose infusion rate required to maintain euglycemia quantifies insulin-stimulated glucose metabolism (M, in milligrams per kilogram per minute). In both nonobese and obese young black males, we have demonstrated that with steady-state hyperinsulinemia at a level of 70 to 80 /i.U/mL greater than fasting, endogenous glucose production is completely suppressed during the final 60 minutes of the procedure. 17 Because the target level of steady-state hyperinsulinemia in the present study was at least 70 to 80 /iU/mL greater than fasting, endogenous glucose production is completely suppressed, and the glucose infusion rate required to maintain euglycemia (M) is an adequate index of total insulin-stimulated glucose utilization. 16 Each subject was scheduled to return to the clinical research unit for the euglycemic clamp procedure. At 8 AM, after a 12-hour overnight fast, a 20-gauge catheter was inserted in a distal arm vein for all infusions. A smaller (22-gauge) catheter was inserted in a dorsal vein of the opposite hand for sample withdrawal. The hand with the sampling catheter was kept warm to ensure arterialization of the blood samples. This vascular catheter was flushed with nonheparinized saline after each sample withdrawal to ensure patency. The subject rested for at least 20 minutes after catheter placement. Before the onset of euglycemic hyperinsulinemia, three samples were withdrawn for determination of fasting plasma glucose and fasting plasma insulin concentrations. Euglycemic hyperinsulinemia was established with a primed constant infusion of insulin using the method of Rizza et al 16 to compute the priming dose and infusion rate of insulin. The target clamped insulin concentration was 70 to 80 /xU/mL of insulin above fasting concentration, which was achieved with an infusion rate of 30 mU/m 2 per minute. 16 Glucose infusion was administered as 20% dextrose. The precise glucose concentration in the 20% dextrose stock solution was measured, and this value was used in the calculation of the glucose infusion rate with the negative-feedback equation of DeFronzo et al. 15 An IBM/PC was programmed to use this iterative negative-feedback equation, which was amended for 10-minute plasma glucose sampling. Euglycemic hyperinsulinemia was maintained for 120 minutes. During the final 60 minutes of steadystate hyperinsulinemia, insulin-stimulated glucose utilization was determined from the glucose infusion rate. The coefficient of variation for clamped plasma glucose concentration was less than 5% during the final 60 minutes of the procedure. A poststudy urine sample was obtained and analyzed for glucose.
Glucose was administered as 20% dextrose in water (Abbott, Chicago, 111). Insulin (Eli Lilly & Co, Indianapolis, Ind) was mixed with normal saline to a concentration of 1000 mU/mL. All solutions were delivered by syringe pumps (model 22, Harvard Apparatus, Cambridge, Mass). Plasma glucose concentration was analyzed with the glucose oxidase technique (Glucostat, model 27, Yellow Springs Instrument Co, Yellow Springs, Ohio). Plasma insulin concentration was determined with a solid-phase radioimmunoassay (Coat-ACount, Diagnostic Products Corp, Los Angeles, Calif). Plasma C peptide concentration was determined by radioimmunoassay (Diagnostic Products). 
Data Analysis
The following methods for statistical analysis of the data were used: Two-way analysis of variance (ANOVA) was used to test for significant differences in means (normotensive versus borderline hypertensive subjects, and men versus women). Tests for interactions were conducted between blood pressure groups and gender groups. Blood pressure group and gender group means were compared using body mass index (BMI) as a covariate in an analysis of covariance. Instead of using a repeated-measures ANOVA and post hoc / tests for the OGTT data, we compared plasma insulin and C peptide levels at each time point separately and used the total sum of insulin and C peptide to compare the entire curves across all time points. Differences in means and interactions were considered statistically significant at a value of P<S)5. Proportions of high versus low BMI between blood pressure groups and gender groups were compared with a x 2 test. Bivariate correlations among numerically continuous variables were examined with Pearson correlation coefficients.
Stepwise multiple linear regressions were used to examine multiple correlations among variables and to build a regression model of the measures of insulin-stimulated glucose utilization (M) on other variables.
Results
Our study sample was drawn from a population that has been studied longitudinally since childhood.
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Repeated measurements of blood pressure, weight, and anthropometric measurements from adolescence are on file for each subject studied. Enrollment assessment, OGTT, and the euglycemic hyperinsulinemic clamp procedure were completed on 50 subjects, which is the population group included in this report. The study group consisted of normotensive and borderline hypertensive young adult blacks without clinical abnormalities in carbohydrate metabolism. We have previously categorically denned our population as normotensive (blood pressure, <135 mm Hg systolic and <85 mm Hg diastolic) or borderline hypertensive (blood pressure, >135 mm Hg systolic or >85 mm Hg diastolic) based on repeated measurements of blood pressure since late adolescence. 9 -20 More men than women completed the clamp procedure. Descriptive data on this clinical sample are provided in Table 1 . All participants were within a narrow age range, with an overall group average of 26 years. According to definition, those with borderline hypertension had significantly higher systolic and diastolic blood pressures than normotensive individuals. Both weight and BMI were significantly greater in the borderline hypertensive compared with the normotensive subjects. Overall, 30% of the men and 46% of the women were obese, defined as BMI equal to or greater than 28 kg/m 2 . The results of the measurement of fasting plasma insulin concentration and the plasma insulin response to glucose load during the OGTT are presented in Table 2 . The ANOVA demonstrated that the fasting plasma insulin concentration was significantly greater (P<.02) in the borderline hypertensive compared with normotensive subjects. After the glucose load, the insulin concentration was consistently higher in women compared with men in both of the blood pressure groups. At 30 and 120 minutes, the gender difference in plasma insulin concentration reached statistical significance (P<.02 and P<.00l, respectively). The sum of insulin values during the OGTT was also significantly greater in women than men (F=.OO9).
Comparison of plasma insulin responses during the OGTT showed that the insulin levels were greater in borderline hypertensive compared with normotensive subjects; however, the variability of insulin within groups and the gender difference in plasma insulin concentration did not permit this difference to achieve statistical significance at individual postglucose time points. However, the sum of insulin concentrations was statistically greater in the borderline hypertensive compared with normotensive subjects (P=.O4). Analysis of the C peptide data obtained during the OGTT also demonstrated significantly higher plasma C peptide concentrations in borderline hypertensive than in normotensive subjects in the fasting state (P=.O2, Table 3 ).
After the glucose load, the differences in plasma C peptide concentration were not significant between the two blood pressure groups. The mean plasma C peptide concentration was higher in women than men within each blood pressure group; however, this difference did not reach statistical significance at this sample size. Both the blood pressure group differences and the gender differences in plasma insulin concentration during the OGTT were more apparent when we examined the insulin-to-glucose ratio (I/G) as an index of the relative amount of plasma insulin response to prevailing glycemia. These values are presented in Table 4 . There was a statistically significant difference in I/G between borderline hypertensive and normotensive subjects fasting and at 30 and 120 minutes after the glucose load. Although I/G was higher in borderline hypertensive men compared with normotensive men, within each blood pressure group, the women had I/G ratios higher than those of men. The gender difference in I/G ratio was statistically significant, both fasting and after glucose load, and this difference overrode the I/G difference between blood pressure groups. All group-sex interaction statistical tests on the metabolic parameters were not significant. Where significant group and sex differences were determined, BMI was a statistically significant covariate.
The results of the euglycemic hyperinsulinemic clamp procedures are presented in Table 5 and Figs 1 and 2.
Mean plasma insulin concentration during steady-state hyperinsulinemia was similar in normotensive and borderline hypertensive subjects (Table 5 ). Although there were apparent gender differences (Fig 1) , M was significantly lower in borderline hypertensive compared with normotensive subjects (4.69 ±0.50 versus 6.57 ±0.63 mg/kg per minute, /"=.002). The use of the same insulin infusion rate in all subjects resulted in a range of steady-state hyperinsulinemia (I, in microunits per milliliter). To adjust for this range, in each case we corrected M for the level of achieved hyperinsulinemia during the clamp by using the quotient of M divided by I to derive an index of insulin sensitivity (MAX 100). 15 This index of insulin sensitivity was also significantly lower in borderline hypertensive compared with normotensive subjects (6.11 ±0.75 versus 9.59±1.05 mg/kg per minute per 100 JAU insulin per milliliter, F=.015). Table 5 provides the numerical values for the blood pressure and gender groups. Fig 2 depicts the clamp data for each subject in this study population of young black normotensive and borderline hypertensive individuals by plotting the quantitative measure of insulinstimulated glucose metabolism (M) relative to the level of steady-state hyperinsulinemia during the clamp for each case. Normotensive subjects demonstrated a progressive increase in M, or insulin-stimulated glucose utilization, with increasing levels of insulin stimulation (I), resulting in the expected significant correlation (r=.552, ,P<.002). As indicated in Fig 2, the borderline hypertensive subjects exhibited a blunted increase in M with increasing levels of insulin stimulation. When the correlation analysis was applied to the data on the borderline hypertensive subjects, there was no significant correlation of M with level of steady-state hyperinsulinemia (r=.O56, P=.751). On the other hand, there was a significant negative correlation of M with fasting plasma insulin concentration in borderline hypertensive subjects (r= -.453, P<.01); in the normotensive subjects, there was no significant correlation between fasting plasma insulin concentration and M (r=.222). As with plasma insulin concentration, both fasting and during OGTT, M was strongly determined by BMI. Because the borderline hypertensive subjects in this study exhibited more adiposity, we determined the contribution of blood pressure, BMI, and plasma insulin concentration to the measured value of M with a stepwise multiple linear regression analysis performed on the entire study group. All independent variables were entered into the model for total M. Results of this analysis are summarized in Table 6 . The stepwise analysis demonstrated that there were significant multiple correlations of M with BMI, clamped insulin, blood pressure group, and systolic blood pressure (multiple #=.7862, P<.001). Although BMI was a major determinant of M or insulin resistance, blood pressure group and systolic blood pressure clearly added statistical strength to the model. To control for the effect of adiposity on insulin resistance, we performed the stepwise multiple linear regression analysis on all subjects having a BMI less than 28 kg/m 2 («=33). In this model, there were significant multiple correlations of M with sex, blood pressure group, and systolic blood pressure (Table 6 , BMI <28 kg/m 2 ; multiple #=.6817, P<.001). On the other hand, when the stepwise multiple linear regression analysis was performed on all subjects having a BMI equal to or greater than 28 kg/m 2 (n = 17), the only significant correlation that emerged was BMI (Table 6, BMI >28 kg/m 2 ; multiple R=.6238, P=.OO7). The analysis indicated that, in this population of young adults, there was a significant correlation of blood pressure and blood pressure group with insulin-stimuInsulin-stimulated Glucose Utilization lated glucose utilization that was independent of adiposity. The lower M value detected in young adult blacks with only borderline hypertension reflects the presence of insulin resistance, and the insulin resistance is not entirely dependent on associated adiposity.
Discussion
In this study on clinically well, young adult black men and women, insulin resistance and higher plasma insulin concentrations were detected only in the group with borderline hypertension. The repeated examination of this population since adolescence verifies the blood pressure status of those subjects classified as borderline hypertensive. In the present study, there is a strong association of both plasma insulin concentration and insulin resistance (M) with body weight and adiposity. However, there is also a correlation, independent of BMI, of both blood pressure and blood pressure status with M. Another significant observation in this study is the gender difference in both plasma insulin concentration (fasting and glucose-stimulated) and M. Both normotensive and borderline hypertensive women had higher plasma insulin concentrations and lower insulinstimulated glucose utilization during the clamp than their male counterparts in each blood pressure group.
Several cross-sectional clinical studies have reported an association of insulin resistance with essential hypertension. 46 More recent studies, which have also addressed the issue of BMI and obesity in the analysis, have confirmed a significant effect of insulin on blood pressure, independent of obesity. strong relation of obesity, in terms of BMI, with measures of insulin resistance, including M, M/I, fasting insulin, or sum of insulin on OGTT. The strong colinearity of obesity, blood pressure, and insulin resistance obscured the relations between blood pressure and insulin resistance. When we excluded the obese and performed a stepwise multiple regression analysis, we were able to detect the relations between blood pressure and insulin resistance. A BMI of 28 kg/m 2 was chosen as the cutoff point for obesity, because this value was close to the National Health and Nutritional Examination Survey II criteria for overweight (BMI >27.8 kg/m 2 in men and >27.3 kg/m 2 in women). 23 In this report, the young black population under study was preclinical, in that those subjects with elevated blood pressure were regarded as only borderline hypertensive, and none were receiving antihypertensive medication. Also, none of the subjects in this study had NIDDM. When the individual cases were examined, a few («=3) did meet the criteria for impaired glucose tolerance. 24 These data suggest that insulin resistance, as characterized in the metabolic studies, is present in the early phase of hypertension and is not a sequela of essential hypertension.
The Tecumseh Blood Pressure Study examined a predominantly white population in a similar age range and reported higher fasting plasma insulin concentrations and greater plasma insulin-to-glucose ratios in young adults with borderline hypertension and a strong family history of hypertension. 8 Zavaroni et al 25 selected clinically well, nonobese adults with elevated fasting plasma insulin concentrations and compared them with age-and weight-matched normal subjects. Compared with normal subjects, those with elevated plasma insulin concentrations also had higher blood pressure and impaired carbohydrate tolerance. These investigators have also studied the young adult offspring of parents with elevated plasma insulin concentrations and found that the offspring exhibited a greater insulin response to a glucose challenge and had significantly higher blood pressure when compared with the offspring of parents with normal plasma insulin concentrations. 26 In an alternative offspring design, Ferrari et al 27 compared BMI, body mass index; BP, blood pressure.
•Average plasma insulin concentration during clamp.
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nonobese offspring of one hypertensive parent with offspring of normotensive parents. In the young adult offspring (mean age, 24 years), those having a hypertensive parent had significantly higher blood pressure, higher fasting plasma insulin concentrations, and significantly lower insulin sensitivity compared with those having two normotensive parents. These reports indicate that the correlation of hyperinsulinemia with blood pressure exists at a young age and that this association is present before the clinical expression of either essential hypertension or NIDDM. The concurrent alterations in carbohydrate metabolism suggest that hyperinsulinemia occurs in response to a defect in insulin-mediated glucose utilization or to insulin resistance. 28 This concept is strengthened by a recent report by Haffner et al 14 from the San Antonio Heart Study. In a prospective biracial study, these investigators detected a subgroup of nonobese normotensive individuals with higher plasma insulin concentrations who became hypertensive over the 8-year follow-up period, suggesting that in this subgroup the hyperinsulinemia was predictive of developing clinical hypertension.
Most investigations that report an association of plasma insulin concentrations with elevated blood pressure have been conducted on white populations. Haffner et al 14 reported a stronger relation of hyperinsulinemia with hypertension in non-Hispanic whites than in the Hispanic sample of the San Antonio Heart Study. In a multiracial study, which included quantitative measures of insulin-stimulated glucose utilization, Saad et al 13 found no correlation of plasma insulin concentration or of insulin resistance with blood pressure in black subjects, whereas there was a significant correlation present in Native American and white subjects. However, the design of this study excluded hypertensive subjects. All normotensive subjects in each racial group were obese. The CARDIA study on young adults did demonstrate a positive correlation of fasting plasma insulin concentration with blood pressure that remained significant after adjustment for BMI in both black and white subjects. 29 This association has also been detected in childhood; data from the Bogalusa Heart Study show that fasting plasma insulin levels track in older children (9 to 14 years), correlate with blood pressure and ponderousness, and are significantly higher in black children. 30 In an earlier study on only nonobese young black men drawn from our population, we detected both higher fasting plasma insulin concentrations and insulin resistance in those with only borderline hypertension. 9 These reports are consistent with the observations in the present study. Relative insulin resistance is a phenotype associated with essential hypertension; it can be detected in the early phases of hypertension and occurs in black as well as white, Hispanic, and Native American subjects.
The hypothetical pathways for explaining the linkage of insulin resistance with essential hypertension include augmented sympathetic nervous system activity, cytosolic calcium homeostasis, ion transport kinetics, and enhanced renal sodium retention.
3 - 28 The pathways that could link insulin resistance, through chronic hyperinsulinemia, with essential hypertension are based on the concept that a defect in one facet of insulin action, eg, insulin-mediated glucose utilization, does not imply that all other effects of insulin are equally blunted. 31 Some of these proposed pathways are more plausible in essential hypertension among blacks, which is characterized by blood pressure sensitivity to sodium, enhanced vascular response to adrenergic stimulation, and increased peripheral vascular resistance.
32
- 33 In our population of young adult blacks, we have detected elevated transport rates in the sodium-hydrogen exchange in red blood cells in subjects with both borderline hypertension and insulin resistance. 34 We have also found in the same young black population a significant correlation of plasma insulin levels during the OGTT with measures of blood pressure sensitivity to sodium loading. 35 Another possible explanation for the coexistence of insulin resistance and essential hypertension is the presence of structural vascular changes, either primary or secondary to the hypertension. In the presence of vascular rarefaction, insulin resistance could be induced as a compensatory response to overcome the impaired glucose delivery to peripheral tissues. 21 However, we demonstrated considerable insulin resistance and hyperinsulinemia in subjects who are young and have only borderline hypertension. Additionally, a few subjects with high blood pressure had normal insulin sensitivity; therefore, changes in the peripheral resistance vessels, if present, must be slight.
A striking finding in this study is the gender difference in plasma insulin concentration and insulin sensitivity. Women exhibited higher plasma insulin concentrations, both fasting and glucose stimulated, and lower insulin sensitivity compared with their male counterparts in both the normotensive and borderline hypertensive groups. Although our sample size for the women in each blood pressure group was small, both the two-way ANOVA and the stepwise multiple regression analysis confirmed the significance of gender in plasma insulin level and insulin sensitivity. This difference may be due to other factors that affect insulin sensitivity, such as a higher percentage of adipose mass in women or possibly a more sedentary level of physical activity. Although not directly addressed, a report from the San Antonio Heart Study does present significant gender differences in both plasma insulin and glucose levels 2 hours after glucose load, 21 and these values are very similar to those observed in our study. It will be important to determine whether these gender differences can be replicated in other studies and also whether the gender differences are consistent across different racial populations. From our data it is apparent that when insulin and insulin sensitivity data on men and women are combined for analysis, both the effect on blood pressure and the differences between blood pressure groups are attenuated. The role of gender in insulin resistance and hypertension warrants further investigation.
Data from this study demonstrate a significant correlation of insulin resistance with both blood pressure and the borderline hypertension status in young adult blacks. BMI is a strong correlate of both plasma insulin concentration and insulin-stimulated glucose utilization. However, analysis of the data in this study indicates that there is a significant correlation of blood pressure with measures of insulin sensitivity independent of BMI. There is also a strong gender effect on plasma insulin level and measures of insulin sensitivity. The reduced insulin sensitivity in this young population may be an expression of a primary cellular defect in insulin action, or the hyperinsulinemia and insulin re-sistance may be augmented by environmental effects such as diet. Further studies will be necessary to distinguish genetic causes of insulin resistance from environmental causes and to determine the extent to which these metabolic alterations can be modified.
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